Skip to main content
Premium Trial:

Request an Annual Quote

Gugger Steps Down as Icoria CEO as Company Continues to Re-Focus On Healthcare

NEW YORK, May 11 (GenomeWeb News) - Icoria CEO Heinrich Gugger resigned, the company said today. The announcement came less than two months after the company sold its agricultural genomics assets for $6.8 million to Monsanto to focus its energy on biomarker discovery.

 

Gugger, who served as president of Syngenta's crop-protection business before joining Icoria in 2003 when it was known as Paradigm Genetics, will be replaced by Doug Morton as interim CEO. Morton joined Icoria's board in 2004 and its "office of the president," which was formed in March.

 

In addition to Gugger, Keith Davis, Icoria's vice president of agricultural biotechnology, and Jim Bucci, VP of human resources, will also be leaving Icoria effective June 30. Davis had also served with Morton and Gugger in the office of the president.

 

According to Icoria, Gugger will remain a company director and will consult during a transition period until the end of June and Morton will retain his position as CEO of Southwest Michigan Innovation Center, a biotech incubator, until Icoria has found a permanent CEO.

 

The company also reported that Barry Buzogany, currently Icoria's vice president, general counsel, and secretary, has been named chief operating officer and Thomas Colatsky, currently vice president of healthcare research, will continue as chief scientific officer

 

The company attributed the senior level turnover to its decision to focus exclusively on health care.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.